Novocure (NVCR) Tops Q3 EPS by 7c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.46), $0.07 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $127.3 million versus the consensus estimate of $128.75 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival shares drop despite earnings beat on weak guidance
• Morgan Stanley lifts server market TAM to $809B, boosts targets on compute stocks